Mitochondrial dysfunction (MDF) has been identified as an important factor in various
diseases ranging from neurological disorders, to diseases of the cardiovascular system and …

… (COX-2) selective inhibitors suggested as potential anticancer therapies. In recent years, the
… Indeed, nanoparticles of cytotoxic drug carriers have demonstrated potential through their …

Antitumor ribonucleases are small (10–28kDa) basic proteins. They were found among
members of both, ribonuclease A and T1 superfamilies. Their cytotoxic properties are conferred …

… Potential toxicity of TRAIL on normal cells Requirements for anticancer therapies include
high antitumor efficacy and low toxicity for normal cells. Various recombinant versions of human …

… Many ligands/receptors of the TNF superfamily are under investigation as potential anticancer
agents. Ligands, except LTα and VEGI that are secreted (inner list, encircled), are type-II …

… , however, it is a potential anticancer treatment due to its nontoxicity towards healthy cells
[26]. This makes graviola an exciting new possible therapy especially in comparison to the …

… for their potential applications in anti-cancer therapies. In this review article, the main
molecular mechanisms of action of flavonoids attributing to their potential anti-cancer activities …

… Should a definite link between tumor development and WASP members be made, different
approaches could be taken when developing potential anticancer/antimetastatic drugs …

Protein kinase C (PKC) comprises a family of isozymes (α, βI, βII,γ δ, ε, θ,& eegr;, λ/ι [mouse/human],
and ζ) which are involved in signal transduction from membrane receptors to the …

… This review will discuss recent advances in our understanding of the relevance of autophagy
for improving anticancer therapy. A summary of the potential novel agents which target …